世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

ラテンアメリカの免疫組織化学市場予測 2018-2026年

LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET FORECAST 2018-2026

 

出版社 出版年月電子版価格 ページ数
Inkwood Research
インクウッドリサーチ
2018年4月US$1,250
シングルユーザライセンス
72

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

サマリー

この調査レポートはラテンアメリカの免疫組織化学市場を分析・予測したInkwood Researchの市場調査報告書です。

Description

KEY FINDINGS
The immunohistochemistry market in Latin America is proliferating with a CAGR of 7.67% during the forecasting years 2018-2026. Technological advancement is one of the driving factors for the growth of the market in the region.
MARKET INSIGHTS
The Latin America immunohistochemistry market is segmented into applications, product, and end-users. The countries mentioned in the market report for the region are Mexico, Brazil, Chile, Argentina, Cuba, Chile, and rest of Latin America. The various end-users augmenting the growth of immunohistochemistry market are hospitals and diagnostic laboratories, research institutes, and others. Brazil dominates the region, owing to the growing elderly population and growing healthcare expense. Also, Mexico is the fastest evolving country in the region.
COMPETITIVE INSIGHTS
The notable players present in the market are Bio-Rad Laboratories Inc., Abcam Plc, Thermo Fisher Scientific Inc., Perkinelmer Inc., Merck Millipore, Histologix, F. Hoffmann-La Roche Ag, Agilent Technologies Inc., Siemens Ag Healthcare, Danaher Corporation, Cell Signaling Technology Inc., Abbott Laboratories, Biogenex, and Bio Sb.



目次

Table of Contents

1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. REAGENTS PRODUCTS ARE GROWING AT A SIGNIFICANT RATE
3.2.2. DIAGNOSTICS IS THE MAJORLY USED APPLICATION IN THE MARKET
3.2.3. HOSPITALS AND DIAGNOSTIC LABORATORIES HOLDS THE LARGEST SHARE IN THE END-USERS MARKET
4. MARKET DETERMINANTS
4.1. MARKET DRIVERS
4.1.1. RISING CANCER INCIDENCE
4.1.2. TECHNOLOGICAL EXPANSIONS IN IN-VITRO DIAGNOSTIC COMMERCE
4.1.3. INCREASING HEALTHCARE SPENDING
4.1.4. GROWING POPULARITY OF POC TESTING
4.2. MARKET RESTRAINTS
4.2.1. LIMITATIONS OF CLOSED SYSTEMS
4.2.2. PRESENCE OF AN UNDIAGNOSED POPULATION
4.3. MARKET OPPORTUNITIES
4.3.1. USE OF BIOMARKERS FOR DISEASE DIAGNOSIS AND INCREASING EFFICIENCY
4.3.2. PARADIGM SHIFT TOWARD PRECISION DIAGNOSIS THROUGH PERSONALIZED MEDICINE
4.3.3. ADVANCEMENTS IN TECHNOLOGIES
4.4. MARKET CHALLENGES
4.4.1. HIGH INITIAL INVESTMENT AND MAINTENANCE COST
4.4.2. STRINGENT REGULATION FOR APPROVAL OF DEVICES
4.4.3. PRICING PRESSURE COUPLED WITH LACK OF PRODUCT DIFFERENTIATION
5. MARKET SEGMENTATION
5.1. MARKET BY PRODUCTS 2018-2026
5.1.1. ANTIBODIES
5.1.1.1. PRIMARY ANTIBODIES
5.1.1.2. SECONDARY ANTIBODIES
5.1.2. EQUIPMENT
5.1.2.1. SLIDE STAINING SYSTEMS
5.1.2.2. TISSUE MICROARRAYS
5.1.2.3. TISSUE PROCESSING SYSTEMS
5.1.2.4. SLIDE SCANNERS
5.1.2.5. OTHER EQUIPMENT’S
5.1.3. REAGENTS
5.1.3.1. HISTOLOGICAL STAINS
5.1.3.2. BLOCKING SERA AND REAGENTS
5.1.3.3. CHROMOGENIC SUBSTRATES
5.1.3.4. FIXATION REAGENTS
5.1.3.5. STABILIZERS
5.1.3.6. ORGANIC SOLVENTS
5.1.3.7. PROTEOLYTIC ENZYMES
5.1.3.8. DILUENTS
5.1.4. KITS
5.2. MARKET BY APPLICATIONS 2018-2026
5.2.1. DIAGNOSTICS
5.2.1.1. CANCER
5.2.1.2. INFECTIOUS DISEASES
5.2.1.3. CARDIOVASCULAR DISEASE
5.2.1.4. AUTOIMMUNE DISEASES
5.2.1.5. DIABETES MELLITUS
5.2.1.6. NEPHROLOGICAL DISEASES
5.2.2. DRUG TESTING
5.3. MARKET BY END-USERS 2018-2026
5.3.1. HOSPITALS AND DIAGNOSTIC LABORATORIES
5.3.2. RESEARCH INSTITUTES
5.3.3. OTHER END-USERS
6. KEY ANALYTICS
6.1. IMMUNOHISTOCHEMISTRY ETYMOLOGY
6.2. VALUE CHAIN ANALYSIS
6.2.1. RAW MATERIAL SUPPLIERS
6.2.2. MANUFACTURERS
6.2.3. DISTRIBUTORS
6.2.4. END-USERS
6.3. OPPORTUNITY MATRIX
7. GEOGRAPHICAL ANALYSIS
7.1. LATIN AMERICA
7.1.1. BRAZIL
7.1.2. MEXICO
7.1.3. ARGENTINA
7.1.4. CHILE
7.1.5. CUBA
7.1.6. REST OF LATIN AMERICA
8. COMPANY PROFILES
8.1. ABBOTT LABORATORIES
8.1.1. COMPANY PROFILE
8.1.2. PRODUCT PORTFOLIO
8.1.3. SWOT ANALYSIS
8.1.4. STRATEGIC INITIATIVES
8.2. ABCAM PLC
8.2.1. COMPANY OVERVIEW
8.2.2. PRODUCT PORTFOLIO
8.2.3. STRATEGIC INITIATIVES
8.3. AGILENT TECHNOLOGIES, INC.
8.3.1. COMPANY OVERVIEW
8.3.2. PRODUCT PORTFOLIO
8.3.3. SCOT ANALYSIS
8.3.4. STRATEGIC INITIATIVES
8.4. BIOGENEX
8.4.1. COMPANY OVERVIEW
8.4.2. PRODUCT PORTFOLIO
8.4.3. STRATEGIC INITIATIVES
8.5. BIO-RAD LABORATORIES, INC.
8.5.1. COMPANY OVERVIEW
8.5.2. PRODUCT PORTFOLIO
8.5.3. SCOT ANALYSIS
8.5.4. STRATEGIC INITIATIVE
8.6. BIO SB
8.6.1. COMPANY OVERVIEW
8.6.2. PRODUCT PORTFOLIO
8.6.3. STRATEGIC INITIATIVES
8.7. CELL SIGNALING TECHNOLOGY, INC.
8.7.1. COMPANY OVERVIEW
8.7.2. PRODUCT PORTFOLIO
8.7.3. SCOT ANALYSIS
8.7.4. STRATEGIC INITIATIVES
8.8. DANAHER CORPORATION
8.8.1. COMPANY OVERVIEW
8.8.2. PRODUCT PORTFOLIO
8.8.3. SCOT ANALYSIS
8.8.4. STRATEGIC INITIATIVES
8.9. F. HOFFMANN-LA ROCHE AG
8.9.1. COMPANY OVERVIEW
8.9.2. PRODUCT PORTFOLIO
8.9.3. SCOT ANALYSIS
8.9.4. STRATEGIC INITIATIVES
8.10. HISTOLOGIX
8.10.1. COMPANY OVERVIEW
8.10.2. PRODUCT PORTFOLIO
8.11. MERCK MILLIPORE
8.11.1. COMPANY OVERVIEW
8.11.2. PRODUCT PORTFOLIO
8.11.3. STRATEGIC INITIATIVES
8.12. PERKINELMER, INC.
8.12.1. COMPANY OVERVIEW
8.12.2. PRODUCT PORTFOLIO
8.12.3. SCOT ANALYSIS
8.12.4. STRATEGIC INITIATIVES
8.13. SIEMENS AG HEALTHCARE
8.13.1. COMPANY OVERVIEW
8.13.2. PRODUCT PORTFOLIO
8.13.3. SCOT ANALYSIS
8.13.4. STRATEGIC INITIATIVES
8.14. THERMO FISHER SCIENTIFIC INC.
8.14.1. COMPANY OVERVIEW
8.14.2. PRODUCT PORTFOLIO
8.14.3. SCOT ANALYSIS
8.14.4. STRATEGIC INITIATIVES





TABLE LIST
TABLE 1 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)
TABLE 2 CANCER MARKERS USED IN DIAGNOSIS AND TREATMENT
TABLE 3 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET BY PRODUCTS 2018-2026 ($ MILLION)
TABLE 4 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN ANTIBODIES 2018-2026 ($ MILLION)
TABLE 5 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN ANTIBODIES -2026 ($ MILLION)
TABLE 6 LATIN AMERICA ANTIBODIES MARKET IN PRIMARY ANTIBODIES 2018-2026 ($ MILLION)
TABLE 7 CLINICALLY IMPORTANT MONOCLONAL ANTIBODIES
TABLE 8 LATIN AMERICA ANTIBODIES MARKET IN SECONDARY ANTIBODIES GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 9 SECONDARY ANTIBODY SELECTION
TABLE 10 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN EQUIPMENT 2018-2026 ($ MILLION)
TABLE 11 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN EQUIPMENT BY TYPES 2018-2026 ($ MILLION)
TABLE 12 LATIN AMERICA EQUIPMENT MARKET IN SLIDE STAINING SYSTEMS 2018-2026 ($ MILLION)
TABLE 13 LATIN AMERICA EQUIPMENT MARKET IN TISSUE MICROARRAYS 2018-2026 ($ MILLION)
TABLE 14 LATIN AMERICA EQUIPMENT MARKET IN TISSUE PROCESSING SYSTEMS 2018-2026 ($ MILLION)
TABLE 15 LATIN AMERICA EQUIPMENT MARKET IN SLIDE SCANNERS 2018-2026 ($ MILLION)
TABLE 16 LATIN AMERICA EQUIPMENT MARKET IN OTHER EQUIPMENT’S 2018-2026 ($ MILLION)
TABLE 17 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN REAGENTS 2018-2026 ($ MILLION)
TABLE 18 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN REAGENTS 2018-2026 ($ MILLION)
TABLE 19 LATIN AMERICA REAGENTS MARKET IN HISTOLOGICAL STAINS 2018-2026 ($ MILLION)
TABLE 20 HISTOLOGY STAINS AND ITS CATEGORIES
TABLE 21 LATIN AMERICA REAGENTS MARKET IN BLOCKING SERA AND REAGENTS 2018-2026 ($ MILLION)
TABLE 22 LATIN AMERICA REAGENTS MARKET IN CHROMOGENIC SUBSTRATES 2018-2026 ($ MILLION)
TABLE 23 LATIN AMERICA REAGENTS MARKET IN FIXATION REAGENTS 2018-2026 ($ MILLION)
TABLE 24 COMMON FIXATIVES AND THEIR GENERAL TARGET ANTIGENS
TABLE 25 LATIN AMERICA REAGENTS MARKET IN STABILIZERS 2018-2026 ($ MILLION)
TABLE 26 LATIN AMERICA REAGENTS MARKET IN ORGANIC SOLVENTS 2018-2026 ($ MILLION)
TABLE 27 LATIN AMERICA REAGENTS MARKET IN PROTEOLYTIC ENZYMES 2018-2026 ($ MILLION)
TABLE 28 LATIN AMERICA REAGENTS MARKET IN DILUENTS 2018-2026 ($ MILLION)
TABLE 29 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN KITS 2018-2026 ($ MILLION)
TABLE 30 AVAILABLE KIT COMPONENTS FOR IHC OPTIMIZATION
TABLE 31 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET BY APPLICATION 2018-2026 ($ MILLION)
TABLE 32 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN DIAGNOSTIC 2018-2026 ($ MILLION)
TABLE 33 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN DIAGNOSTIC BY TYPE 2018-2026 ($ MILLION)
TABLE 34 LATIN AMERICA DIAGNOSTIC MARKET IN CANCER 2018-2026 ($ MILLION)
TABLE 35 LATIN AMERICA DIAGNOSTIC MARKET IN INFECTIOUS DISEASES 2018-2026 ($ MILLION)
TABLE 36 LATIN AMERICA DIAGNOSTIC MARKET IN CARDIOVASCULAR DISEASE 2018-2026 ($ MILLION)
TABLE 37 LATIN AMERICA DIAGNOSTIC MARKET IN AUTOIMMUNE DISEASES 2018-2026 ($ MILLION)
TABLE 38 SELECTED INFECTIOUS ETIOLOGIES OF AUTOIMMUNE DISEASES
TABLE 39 LATIN AMERICA DIAGNOSTIC MARKET IN DIABETES MELLITUS 2018-2026 ($ MILLION)
TABLE 40 LATIN AMERICA DIAGNOSTIC MARKET IN NEPHROLOGICAL DISEASES 2018-2026 ($ MILLION)
TABLE 41 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN DRUG TESTING 2018-2026 ($ MILLION)
TABLE 42 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET BY END USERS 2018-2026 ($ MILLION)
TABLE 43 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN HOSPITALS AND DIAGNOSTIC LABORATORIES 2018-2026 ($ MILLION)
TABLE 44 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN RESEARCH INSTITUTES 2018-2026 ($ MILLION)
TABLE 45 CANCER RESEARCH PROGRAM
TABLE 46 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN OTHER END USERS 2018-2026 ($ MILLION)
TABLE 47 IMMUNOHISTOCHEMISTRY USAGE IN FORENSIC PATHOLOGY
TABLE 48 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)
TABLE 49 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)
TABLE 50 CAUSES OF DEATH IN ARGENTINA IN 2016
TABLE 51 CAUSES OF DEATH IN CUBA 2016


FIGURES LIST
FIGURE 1 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)
FIGURE 2 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN ANTIBODIES 2018-2026 ($ MILLION)
FIGURE 3 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN EQUIPMENT 2018-2026 ($ MILLION)
FIGURE 4 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN REAGENTS 2018-2026 ($ MILLION)
FIGURE 5 PHASES OF HISTOLOGICAL STAINING
FIGURE 6 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN KITS 2018-2026 ($ MILLION)
FIGURE 7 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN DIAGNOSTIC 2018-2026 ($ MILLION)
FIGURE 8 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN DRUG TESTING 2018-2026 ($ MILLION)
FIGURE 9 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN HOSPITALS AND DIAGNOSTIC LABORATORIES 2018-2026 ($ MILLION)
FIGURE 10 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN RESEARCH INSTITUTES 2018-2026 ($ MILLION)
FIGURE 11 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN OTHER END USERS 2018-2026 ($ MILLION)
FIGURE 12 HISTORY OF IMMUNOHISTOCHEMISTRY
FIGURE 13 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)
FIGURE 14 BRAZIL IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)
FIGURE 15 HEALTHCARE SPENDING IN MEXICO 2014 AND 2040 ($ BILLION)
FIGURE 16 MEXICO IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)
FIGURE 17 HEALTHCARE SPENDING IN ARGENTINA 2014 AND 2040 ($ BILLION)
FIGURE 18 ARGENTINA IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)
FIGURE 19 CHILE IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)
FIGURE 20 HEALTHCARE EXPENDITURE IN CHILE 2005-2016 (PERCENTAGE SHARE OF GDP)
FIGURE 21 HEALTHCARE SPENDING IN CUBA (2014 AND 2040)
FIGURE 22 CUBA IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)
FIGURE 23 REST OF LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

List of Tables

TABLE LIST
TABLE 1 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)
TABLE 2 CANCER MARKERS USED IN DIAGNOSIS AND TREATMENT
TABLE 3 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET BY PRODUCTS 2018-2026 ($ MILLION)
TABLE 4 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN ANTIBODIES 2018-2026 ($ MILLION)
TABLE 5 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN ANTIBODIES -2026 ($ MILLION)
TABLE 6 LATIN AMERICA ANTIBODIES MARKET IN PRIMARY ANTIBODIES 2018-2026 ($ MILLION)
TABLE 7 CLINICALLY IMPORTANT MONOCLONAL ANTIBODIES
TABLE 8 LATIN AMERICA ANTIBODIES MARKET IN SECONDARY ANTIBODIES GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 9 SECONDARY ANTIBODY SELECTION
TABLE 10 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN EQUIPMENT 2018-2026 ($ MILLION)
TABLE 11 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN EQUIPMENT BY TYPES 2018-2026 ($ MILLION)
TABLE 12 LATIN AMERICA EQUIPMENT MARKET IN SLIDE STAINING SYSTEMS 2018-2026 ($ MILLION)
TABLE 13 LATIN AMERICA EQUIPMENT MARKET IN TISSUE MICROARRAYS 2018-2026 ($ MILLION)
TABLE 14 LATIN AMERICA EQUIPMENT MARKET IN TISSUE PROCESSING SYSTEMS 2018-2026 ($ MILLION)
TABLE 15 LATIN AMERICA EQUIPMENT MARKET IN SLIDE SCANNERS 2018-2026 ($ MILLION)
TABLE 16 LATIN AMERICA EQUIPMENT MARKET IN OTHER EQUIPMENT’S 2018-2026 ($ MILLION)
TABLE 17 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN REAGENTS 2018-2026 ($ MILLION)
TABLE 18 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN REAGENTS 2018-2026 ($ MILLION)
TABLE 19 LATIN AMERICA REAGENTS MARKET IN HISTOLOGICAL STAINS 2018-2026 ($ MILLION)
TABLE 20 HISTOLOGY STAINS AND ITS CATEGORIES
TABLE 21 LATIN AMERICA REAGENTS MARKET IN BLOCKING SERA AND REAGENTS 2018-2026 ($ MILLION)
TABLE 22 LATIN AMERICA REAGENTS MARKET IN CHROMOGENIC SUBSTRATES 2018-2026 ($ MILLION)
TABLE 23 LATIN AMERICA REAGENTS MARKET IN FIXATION REAGENTS 2018-2026 ($ MILLION)
TABLE 24 COMMON FIXATIVES AND THEIR GENERAL TARGET ANTIGENS
TABLE 25 LATIN AMERICA REAGENTS MARKET IN STABILIZERS 2018-2026 ($ MILLION)
TABLE 26 LATIN AMERICA REAGENTS MARKET IN ORGANIC SOLVENTS 2018-2026 ($ MILLION)
TABLE 27 LATIN AMERICA REAGENTS MARKET IN PROTEOLYTIC ENZYMES 2018-2026 ($ MILLION)
TABLE 28 LATIN AMERICA REAGENTS MARKET IN DILUENTS 2018-2026 ($ MILLION)
TABLE 29 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN KITS 2018-2026 ($ MILLION)
TABLE 30 AVAILABLE KIT COMPONENTS FOR IHC OPTIMIZATION
TABLE 31 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET BY APPLICATION 2018-2026 ($ MILLION)
TABLE 32 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN DIAGNOSTIC 2018-2026 ($ MILLION)
TABLE 33 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN DIAGNOSTIC BY TYPE 2018-2026 ($ MILLION)
TABLE 34 LATIN AMERICA DIAGNOSTIC MARKET IN CANCER 2018-2026 ($ MILLION)
TABLE 35 LATIN AMERICA DIAGNOSTIC MARKET IN INFECTIOUS DISEASES 2018-2026 ($ MILLION)
TABLE 36 LATIN AMERICA DIAGNOSTIC MARKET IN CARDIOVASCULAR DISEASE 2018-2026 ($ MILLION)
TABLE 37 LATIN AMERICA DIAGNOSTIC MARKET IN AUTOIMMUNE DISEASES 2018-2026 ($ MILLION)
TABLE 38 SELECTED INFECTIOUS ETIOLOGIES OF AUTOIMMUNE DISEASES
TABLE 39 LATIN AMERICA DIAGNOSTIC MARKET IN DIABETES MELLITUS 2018-2026 ($ MILLION)
TABLE 40 LATIN AMERICA DIAGNOSTIC MARKET IN NEPHROLOGICAL DISEASES 2018-2026 ($ MILLION)
TABLE 41 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN DRUG TESTING 2018-2026 ($ MILLION)
TABLE 42 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET BY END USERS 2018-2026 ($ MILLION)
TABLE 43 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN HOSPITALS AND DIAGNOSTIC LABORATORIES 2018-2026 ($ MILLION)
TABLE 44 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN RESEARCH INSTITUTES 2018-2026 ($ MILLION)
TABLE 45 CANCER RESEARCH PROGRAM
TABLE 46 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET IN OTHER END USERS 2018-2026 ($ MILLION)
TABLE 47 IMMUNOHISTOCHEMISTRY USAGE IN FORENSIC PATHOLOGY
TABLE 48 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)
TABLE 49 LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)
TABLE 50 CAUSES OF DEATH IN ARGENTINA IN 2016
TABLE 51 CAUSES OF DEATH IN CUBA 2016

Companies Mentioned

1. ABBOTT LABORATORIES
2. ABCAM PLC
3. AGILENT TECHNOLOGIES, INC.
4. BIOGENEX
5. BIO-RAD LABORATORIES, INC.
6. BIO SB
7. CELL SIGNALING TECHNOLOGY, INC.
8. DANAHER CORPORATION
9. F. HOFFMANN-LA ROCHE AG
10. HISTOLOGIX
11. MERCK MILLIPORE
12. PERKINELMER, INC.
13. SIEMENS AG HEALTHCARE
14. THERMO FISHER SCIENTIFIC INC.

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る